Terms: = Ovarian cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Treatment
4 results:
1. METTL3/YTHDF1 m
Zhi D; Zhou K; Liu S; Yu W; Dong M; Yan C
Pathol Res Pract; 2024 Jan; 253():155047. PubMed ID: 38154356
[TBL] [Abstract] [Full Text] [Related]
2. Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced ovarian cancer Aggressiveness.
Jeong BY; Cho KH; Yoon SH; Park CG; Park HW; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065317
[TBL] [Abstract] [Full Text] [Related]
3. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract] [Full Text] [Related]
4. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
[TBL] [Abstract] [Full Text] [Related]